
After a two year delay, Novo Nordisk has started launching the company's smart reusable insulin pens Novopen 6 and Novopen Echo Plus.
The first launch will revolve around Sweden, but will soon be expanded to Western Europe and many other countries in due course, Novo Nordisk Corporate Vice President, Commercial Innovation (Digital Health, Commercial Digital Lighthouse, Patient Support Solutions and Device Marketing) Anders Dyhr Toft tells MedWatch.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app